Search
Aldeyra Therapeutics Inc
ALDXAdd to Watchlist
1.540USD
-0.060-3.75%
Close 07-31 16:00（ET）Quotes delayed by 15 min
92.89MMarket Cap
LossP/E TTM
ALDX Financials
See Aldeyra Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Aldeyra Therapeutics Inc Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-0.06/-0.10
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.56
39.98%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its current assets were 71.78M, with a year-on-year change of -31.03.
What are the total assets of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its total assets of Aldeyra Therapeutics Inc were 72.06M, with a year-on-year change of -31.11.
What are the total liabilities of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its total liabilities of Aldeyra Therapeutics Inc were 27.81M, with a year-on-year change of -17.24.
What is the total equity of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its total equity of Aldeyra Therapeutics Inc was 44.25M, with a year-on-year change of -37.68.
What is the net operating income of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its net operating income of Aldeyra Therapeutics Inc was -35.27M, with a year-on-year change of 41.34.
What is the net investment of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its net investment of Aldeyra Therapeutics Inc was 47.74M, with a year-on-year change of 206.28.
What is the net financing of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its net financing of Aldeyra Therapeutics Inc was 1.12M, with a year-on-year change of 755.43.
What is the Earnings Per Share (EPS) of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.56, with a year-on-year change of 39.98.
What is the net income of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its net income was -33.85M, with a year-on-year change of 39.40.
What is the debt-to-asset ratio of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 21.16, with a year-on-year change of 47.28.
What is the Return on Equity (ROE) of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -58.73, with a year-on-year change of -0.32.
What is the Return on Assets (ROA) of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -38.32, with a year-on-year change of 13.24.
What is the operating profit of Aldeyra Therapeutics Inc?
According to Aldeyra Therapeutics Inc's FY2025 earnings report, its operating profit was -35.27M, with a year-on-year change of 41.34.